Omega-3 Levels in Prenatal Supplements

Mary J. Scourboutakos,Elenee H. Harper,Michael T. Kopec,Lauren Rose,Milena Forte
DOI: https://doi.org/10.1055/a-2465-5163
2024-12-06
American Journal of Perinatology
Abstract:Objective This study aimed to systematically document the reported omega-3 levels in commercially available prenatal supplements in the United States and Canada, and compare these levels to recommended intakes in pregnancy. Study Design Commercial prenatal supplements were identified using the Dietary Supplement Label Database ( n = 50) and the Licensed Natural Health Products Database ( n = 18). Mean omega-3 levels and the proportion of products meeting recommendations for pregnant women were tabulated. Results Average omega-3 levels were 368 ± 33 mg in the United States and 404 ± 72 mg in Canada. Seventy percent of products in the United States and 61% in Canada contained the amount of omega-3 levels recommended for pregnant women with sufficient intakes. Sixteen percent of products in the United States and 28% in Canada contained the dose recommended for pregnant women with insufficient intakes. Conclusion These results illustrate that commercial prenatal supplements contain a wide variety of omega-3 fatty acid levels that may or may not be consistent with recommended intake levels. Key Points most pregnant women consume inadequate amounts of omega-3 fatty acids. omega-3 fatty acids can help prevent preterm birth. new guidelines recommend increased intakes of omega-3 fatty acids during pregnancy. prenatal supplements contain a wide variety of omega-3 fatty acid levels. omega-3 levels in prenatal supplements may or may not be consistent with recommended intake levels. M.J.S. takes responsibility for the integrity of the data and the accuracy of the data analysis. M.J.S. conceived the study. M.J.S., E.H.H., M.T.K., L.R., and M.F. designed the study. M.J.S. and Harper acquired the data. M.J.S. analyzed and interpreted the data and wrote the manuscript. M.J.S., E.H.H., M.T.K., L.R., and M.F. reviewed the manuscript for important intellectual content and approved the final version. M.F. and M.T.K. supervised the study. Received: 09 July 2024 Accepted: 11 November 2024 Article published online: 04 December 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
pediatrics,obstetrics & gynecology
What problem does this paper attempt to address?